Kyung-Hun Lee

10.6k total citations · 2 hit papers
216 papers, 6.0k citations indexed

About

Kyung-Hun Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kyung-Hun Lee has authored 216 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Oncology, 79 papers in Pulmonary and Respiratory Medicine and 46 papers in Cancer Research. Recurrent topics in Kyung-Hun Lee's work include Advanced Breast Cancer Therapies (32 papers), HER2/EGFR in Cancer Research (30 papers) and Breast Cancer Treatment Studies (27 papers). Kyung-Hun Lee is often cited by papers focused on Advanced Breast Cancer Therapies (32 papers), HER2/EGFR in Cancer Research (30 papers) and Breast Cancer Treatment Studies (27 papers). Kyung-Hun Lee collaborates with scholars based in South Korea, United States and Ethiopia. Kyung-Hun Lee's co-authors include Seock‐Ah Im, Do‐Youn Oh, Sae‐Won Han, Yung‐Jue Bang, Tae‐Yong Kim, Tae‐You Kim, Hope S. Rugo, Sara A. Hurvitz, Joanne L. Blum and Jennifer K. Litton and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kyung-Hun Lee

209 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

2018 1.4k citations Jennifer K. Litton, Hope S. Rugo et al. New England Journal of Medicine profile →
Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer

2018 467 citations Kyung-Hun Lee, Do‐Youn Oh et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kyung-Hun Lee	4.1k	2.0k	1.6k	1.5k	706	216	6.0k
Hagen F. Kennecke	3.6k 0.9×	1.4k 0.7×	1.4k 0.8×	1.9k 1.2×	686 1.0×	156	5.5k
Daniele Generali	3.1k 0.8×	1.7k 0.9×	2.5k 1.5×	2.1k 1.4×	429 0.6×	232	6.2k
Alessandro Morabito	4.8k 1.2×	3.4k 1.7×	1.7k 1.0×	1.7k 1.1×	443 0.6×	217	7.2k
Helen Mackay	2.9k 0.7×	1.2k 0.6×	2.9k 1.8×	1.3k 0.8×	787 1.1×	185	7.1k
Young Kwang Chae	3.1k 0.8×	1.9k 0.9×	2.6k 1.6×	1.7k 1.1×	777 1.1×	274	6.4k
Hellmut Samonigg	4.0k 1.0×	1.2k 0.6×	1.9k 1.2×	2.9k 1.9×	750 1.1×	118	6.6k
Alexandra Léary	3.5k 0.8×	973 0.5×	2.0k 1.2×	1.3k 0.8×	879 1.2×	280	7.5k
Steven G. DuBois	2.0k 0.5×	2.7k 1.4×	2.4k 1.5×	1.5k 1.0×	856 1.2×	281	7.4k
Pär‐Ola Bendahl	3.3k 0.8×	1.4k 0.7×	2.7k 1.7×	3.0k 1.9×	644 0.9×	181	6.7k
Anke Reinacher‐Schick	3.1k 0.8×	1.1k 0.6×	1.3k 0.8×	1.4k 0.9×	756 1.1×	158	4.7k

Countries citing papers authored by Kyung-Hun Lee

Since Specialization

Citations

This map shows the geographic impact of Kyung-Hun Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung-Hun Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung-Hun Lee more than expected).

Fields of papers citing papers by Kyung-Hun Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyung-Hun Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung-Hun Lee. The network helps show where Kyung-Hun Lee may publish in the future.

Co-authorship network of co-authors of Kyung-Hun Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Kyung-Hun Lee. A scholar is included among the top collaborators of Kyung-Hun Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung-Hun Lee. Kyung-Hun Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Yeon Hee, Kyung-Hun Lee, Gun Min Kim, et al.. (2024). Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.. Journal of Clinical Oncology. 42(17_suppl). LBA1002–LBA1002. 1 indexed citations

Santoro, Armando, Eric Assénat, Thomas Yau, et al.. (2024). A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma. JHEP Reports. 6(4). 101021–101021. 5 indexed citations

Park, Changhee, Kyung-Hun Lee, Jung Ryeol Lee, et al.. (2023). Fertility Preservation in Young Women With Breast Cancer: A Review. Journal of Breast Cancer. 26(3). 221–221. 8 indexed citations

Kim, Hong Kyu, Seho Park, Min Hyuk Lee, et al.. (2023). Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer. Journal of Breast Cancer. 26(6). 582–582. 3 indexed citations

Chang, Euijin, Song Yi Park, Dae‐Won Lee, et al.. (2022). Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment. The Oncologist. 27(12). e931–e937. 2 indexed citations

Yang, Yaewon, Ahrum Min, Kyung-Hun Lee, et al.. (2020). Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients. Journal of Breast Cancer. 23(2). 182–182. 9 indexed citations

Lee, Dae-Won, Eun Ju Cho, Su Jong Yu, et al.. (2020). Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib. Clinical Cancer Research. 27(3). 713–718. 33 indexed citations

Kim, Miseon, Dong Hoon Suh, Kyung-Hun Lee, et al.. (2020). Major clinical research advances in gynecologic cancer in 2019. Journal of Gynecologic Oncology. 31(3). e48–e48. 11 indexed citations

Kim, Miseon, Dong Hoon Suh, Kyung-Hun Lee, et al.. (2019). Major clinical research advances in gynecologic cancer in 2018. Journal of Gynecologic Oncology. 30(2). e18–e18. 31 indexed citations

10.

Litton, Jennifer K., Hope S. Rugo, Johannes Ettl, et al.. (2018). Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. New England Journal of Medicine. 379(8). 753–763. 1401 indexed citations breakdown →

11.

Suh, Dong Hoon, Miseon Kim, Kyung-Hun Lee, et al.. (2018). Major clinical research advances in gynecologic cancer in 2017. Journal of Gynecologic Oncology. 29(2). e31–e31. 21 indexed citations

12.

Suh, Dong Hoon, Miseon Kim, Kidong Kim, et al.. (2017). Major clinical research advances in gynecologic cancer in 2016: 10-year special edition. Journal of Gynecologic Oncology. 28(3). e45–e45. 24 indexed citations

13.

Nam, Ah-Rong, Ji‐Won Kim, Ji Eun Park, et al.. (2016). Src as a Therapeutic Target in Biliary Tract Cancer. Molecular Cancer Therapeutics. 15(7). 1515–1524. 9 indexed citations

14.

Suh, Dong Hoon, Miseon Kim, Hak Jae Kim, Kyung-Hun Lee, & Jae‐Weon Kim. (2016). Major clinical research advances in gynecologic cancer in 2015. Journal of Gynecologic Oncology. 27(6). 20 indexed citations

15.

Jung, Dooyoung, Won‐Hyoung Kim, Joo-Young Lee, et al.. (2016). Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer. Psychosomatic Medicine. 78(8). 959–965. 22 indexed citations

16.

Ock, Chan-Young, Keun‐Wook Lee, Jin Won Kim, et al.. (2015). Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer. Clinical Cancer Research. 21(11). 2520–2529. 52 indexed citations

17.

Suh, Dong Hoon, Kyung-Hun Lee, Kidong Kim, Sokbom Kang, & Jae‐Weon Kim. (2015). Major clinical research advances in gynecologic cancer in 2014. Journal of Gynecologic Oncology. 26(2). 156–156. 27 indexed citations

18.

Ock, Chan‐Young, Ju‐Hee Bang, Tae-Yong Kim, et al.. (2015). The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.. PubMed Central. 5(11). 3376–88. 13 indexed citations

19.

Min, Ahrum, Seock‐Ah Im, Young‐Kwang Yoon, et al.. (2013). RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib. Molecular Cancer Therapeutics. 12(6). 865–877. 109 indexed citations

20.

Han, Sae‐Won, Tae‐You Kim, Yoon Kyung Jeon, et al.. (2006). Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation. Clinical Cancer Research. 12(8). 2538–2544. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact